Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with hepatocellular carcinoma (a type of liver cancer), including those with more than one tumour — confirmed either by a tissue or cell sample test, or by specific patterns seen on a CT or MRI scan
- People aged 18 or older at the time of signing the consent form
- People whose general physical health and ability to carry out daily activities falls within a certain acceptable range (a rating scale used by doctors to measure this — confirm with trial site)
- People whose liver is functioning within a certain level, as measured by a scoring system called Child-Pugh, tested within 28 days before joining the study
- People who have had a blood test to check for hepatitis B virus
- People who have had a blood test to check for hepatitis C virus
- People who are able to understand the study and are willing to sign a written consent form
Who may not be able to join:
- People whose cancer has spread to distant parts of the body in a way that cannot be treated with radiation therapy
- People who are pregnant, or women who could become pregnant and men who are sexually active but are unwilling or unable to use an acceptable form of contraception
- People whose cancer cannot be fully treated at all affected sites using radiation therapy
- People who have a known HIV infection
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +886-3-3281200
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Progression free survival (PFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.